MA08.06 Stratifying PD-L1 Expression Level Based on Multimodal Genomic Features for the Prediction of Immunotherapy Benefit in NSCLC

• DOI: 10.1016/j.jtho.2021.01.193
• Publication Date: 2021-03-20T05:54:03Z
• Authors: Y. Wang; Y. Li; C. Li; Y. Jiang; X. Han; S. Liu; X. Xu; W. Tang; Q. Ou; H. Bao; X. Wu; Y. Shao; M. Xing; Y. Zhang
• Keywords: Multimodal therapy